Jiaoyang Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jiaoyang Jiang has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Alisa Hui
Department of Chemistry, University of British Columbia, Vancouver, Canada
18 shared publications - Cheri A. Pasch
Division of Hematology, Medical Oncology, and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA
18 shared publications - Chunmiao Cai
Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin–Madison, Madison, Wisconsin
18 shared publications - Ke Wang
Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin–Madison, Madison, Wisconsin
18 shared publications - Tao Huan
Department of Chemistry, Faculty of Science, University of British Columbia, Vancouver Campus, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada
18 shared publications - Brian Low
Department of Chemistry, University of British Columbia, Vancouver, Canada
17 shared publications
Latest Publications
- Open Access
- 15 April 2026
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 5 (4)
Crystal structure of EOGT reveals a conserved N–R–R constellation for UDP recognition in the GT61 family
Epidermal growth factor (EGF) domain-specific O-linked N-acetylglucosamine transferase (EOGT), a glycosyltransferase (GT)-61 family member, catalyzes O-N-acetylglucosamine (GlcNAc) transfer from UDP-GlcNAc to serine or threonine residues within EGF domains in the endoplasmic reticulum. In this study, we determined the crystal structure of the EOGT–uridine diphosphate (UDP) complex and identified the critical residues mediating their interactions, which were validated via site-directed mutagenesis and enzyme activity assays. These residues were conserved in EOGT orthologs across metazoans, and UDP binding occurred independently of divalent metal ions and the canonical Asp–X–Asp motif. Although EOGT catalyzes O-GlcNAcylation, similar to O-GlcNAc transferase (OGT), it shares little sequence similarity with OGT and belongs to a distinct glycosyltransferase family. Instead, EOGT is more closely related to protein O-linked-mannose β1,4-N-acetylglucosaminyltransferase 2 (POMGNT2). Structural comparison with POMGNT2 revealed a conserved triad of one asparagine and two arginine residues, the N–R–R constellation. These elements were conserved across metazoans and green plants (Viridiplantae), suggesting a unifying mechanism of UDP recognition and providing a framework to interpret disease-associated EOGT mutations and assess the evolution of catalytically active GT61 family enzymes.
- 15 April 2026
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 5 (4)
Open AccessCrystal structure of EOGT reveals a conserved N–R–R constellation for UDP recognition in the GT61 family
Epidermal growth factor (EGF) domain-specific O-linked N-acetylglucosamine transferase (EOGT), a glycosyltransferase (GT)-61 family member, catalyzes O-N-acetylglucosamine (GlcNAc) transfer from UDP-GlcNAc to serine or threonine residues within EGF domains in the endoplasmic reticulum. In this study, we determined the crystal structure of the EOGT–uridine diphosphate (UDP) complex and identified the critical residues mediating their interactions, which were validated via site-directed mutagenesis and enzyme activity assays. These residues were conserved in EOGT orthologs across metazoans, and UDP binding occurred independently of divalent metal ions and the canonical Asp–X–Asp motif. Although EOGT catalyzes O-GlcNAcylation, similar to O-GlcNAc transferase (OGT), it shares little sequence similarity with OGT and belongs to a distinct glycosyltransferase family. Instead, EOGT is more closely related to protein O-linked-mannose β1,4-N-acetylglucosaminyltransferase 2 (POMGNT2). Structural comparison with POMGNT2 revealed a conserved triad of one asparagine and two arginine residues, the N–R–R constellation. These elements were conserved across metazoans and green plants (Viridiplantae), suggesting a unifying mechanism of UDP recognition and providing a framework to interpret disease-associated EOGT mutations and assess the evolution of catalytically active GT61 family enzymes.
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
Impact of microbially LCAs on CRC cells growth
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
Impact of microbially LCAs on CRC cells growth
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 10 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA inhibits tumor progression in PDX2 mice
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 10 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA inhibits tumor progression in PDX2 mice
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 13 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA reshape the gut microbiome pool in APCMin/+ mice
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 13 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA reshape the gut microbiome pool in APCMin/+ mice
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA decreases tumor load in CT26-xenograft Balb/c mice
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA decreases tumor load in CT26-xenograft Balb/c mice
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 9 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA decreases tumor load in xenografted mice
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 9 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA decreases tumor load in xenografted mice
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA Inhibits CT26 Cell Growth by Activating FXR Signaling and inducing apoptosis
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA Inhibits CT26 Cell Growth by Activating FXR Signaling and inducing apoptosis
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA stimulates Intestinal Stem Cell (ISC) proliferation in WT intestinal organoids
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA stimulates Intestinal Stem Cell (ISC) proliferation in WT intestinal organoids
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 11 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
The effect of 3-oxo-LCA is FXR-dependent
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 11 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
The effect of 3-oxo-LCA is FXR-dependent